Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Leiper

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Scientific Reports|October 19, 2016
A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2Roman N Rodionov, Elisa Oppici, Jens Martens-Lobenhoffer, et al.
Circulation|March 9, 2011
cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolasesSoni Savai Pullamsetti, Rajkumar Savai, Martina Barbara Schaefer, et al.
Science Translational Medicine|June 17, 2011
The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosisSoni Savai Pullamsetti, Rajkumar Savai, Rio Dumitrascu, et al.
Nature Medicine|February 3, 2007
Disruption of methylarginine metabolism impairs vascular homeostasisJames Leiper, Manasi Nandi, Belen Torondel, et al.
Circulation Research|August 4, 2007
Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NODan Wang, Pritmohinder S Gill, Tinatin Chabrashvili, et al.
Circulation|December 11, 2014
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsBlerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Lancet (London, England)|May 6, 2014
Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation studyVincenzo Libri, Cihangir Yandim, Stavros Athanasopoulos, et al.
Circulation|October 28, 2015
Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"Blerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2015
Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney DamageJames A P Tomlinson, Ben Caplin, Olga Boruc, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 11, 2015
Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsisSimon Lambden, Peter Kelly, Blerina Ahmetaj-Shala, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|October 19, 2016
A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2Roman N Rodionov, Elisa Oppici, Jens Martens-Lobenhoffer, et al.
Circulation|March 9, 2011
cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolasesSoni Savai Pullamsetti, Rajkumar Savai, Martina Barbara Schaefer, et al.
Science Translational Medicine|June 17, 2011
The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosisSoni Savai Pullamsetti, Rajkumar Savai, Rio Dumitrascu, et al.
Nature Medicine|February 3, 2007
Disruption of methylarginine metabolism impairs vascular homeostasisJames Leiper, Manasi Nandi, Belen Torondel, et al.
Circulation Research|August 4, 2007
Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NODan Wang, Pritmohinder S Gill, Tinatin Chabrashvili, et al.
Circulation|December 11, 2014
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsBlerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Lancet (London, England)|May 6, 2014
Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation studyVincenzo Libri, Cihangir Yandim, Stavros Athanasopoulos, et al.
Circulation|October 28, 2015
Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"Blerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2015
Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney DamageJames A P Tomlinson, Ben Caplin, Olga Boruc, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 11, 2015
Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsisSimon Lambden, Peter Kelly, Blerina Ahmetaj-Shala, et al.
Pageof 6